Andrews N, Miller E, Waight P, Farrington P, Crowcroft N, Stowe J, Taylor B
Public Health Laboratory Service Statistics Unit, London, UK.
Eur J Epidemiol. 2001;17(8):701-6. doi: 10.1023/a:1015691619745.
The use of live oral poliomyelitis vaccine (OPV) has led to the elimination of poliomyelitis disease in many countries since licensure in 1960. The discovery of an increased risk of an intestinal obstruction known as intussusception following live rotavirus vaccination raised questions about the possibility of a link between live OPV and intussusception.
Three self-controlled case-series studies were carried out. The first was exploratory and included 218 intussusception episodes from hospital admissions data linked to vaccination records in the Thames region. The two subsequent studies, which used further hospital admissions data and the General Practice Research Database (GPRD) included 107 and 198 episodes respectively and were used to test hypotheses generated in the first study.
In the exploratory study risk periods of up to 6 weeks after each dose were examined. The only period with some evidence of an increased risk was the 14-27-day period after the third dose (relative incidence (RI) = 1.97, p = 0.011). The second hospital admissions study and the GPRD study showed no evidence of an increased relative incidence in any putative risk period and did not confirm the increased risk in the 14-27-day period after dose 3 with a combined RI of 1.03.
The sequence of studies does not support the hypothesis that OPV causes intussusception. The increased RI in the first study may be explained as a chance finding due to the number of risk periods examined and highlights the need for caution when looking at many risk periods without an a priori hypothesis.
自1960年口服脊髓灰质炎减毒活疫苗(OPV)获批使用以来,许多国家已通过使用该疫苗消除了脊髓灰质炎疾病。由于发现口服轮状病毒活疫苗接种后发生肠套叠这种肠梗阻疾病的风险增加,人们开始质疑OPV与肠套叠之间是否存在关联。
开展了三项自我对照病例系列研究。第一项为探索性研究,纳入了泰晤士地区218例与疫苗接种记录相关的因肠套叠入院病例。随后的两项研究分别使用了更多的入院病例数据和全科医学研究数据库(GPRD),各纳入了107例和198例病例,用于检验第一项研究中提出的假设。
在探索性研究中,对每次接种疫苗后长达6周的风险期进行了检查。唯一有一些证据表明风险增加的时期是第三剂疫苗接种后14 - 27天(相对发病率(RI)= 1.97,p = 0.011)。第二项入院病例研究和GPRD研究均未发现任何假定风险期内相对发病率增加的证据,也未证实第三剂疫苗接种后14 - 27天风险增加,综合相对发病率为1.03。
该系列研究结果不支持OPV会导致肠套叠这一假设。第一项研究中相对发病率的增加可能是由于所检查的风险期数量较多而偶然出现的结果,这凸显了在没有先验假设的情况下查看多个风险期时需要谨慎。